| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-2141.1984.TB06055.X |
| P698 | PubMed publication ID | 6466567 |
| P2093 | author name string | Preisler HD | |
| Raza A | |||
| Rai K | |||
| Epstein J | |||
| Barcos M | |||
| Winton E | |||
| Browman GP | |||
| Priore R | |||
| Grunwald H | |||
| Vogler R | |||
| P2860 | cites work | Lethality of human myeloblasts correlates with the incorporation of arabinofuranosylcytosine into DNA | Q35368280 |
| Bone-marrow-profileration patterns in acute myeloblastic leukaemia determined by pulse cytophotometry | Q39323924 | ||
| Failure of remission induction in acute myelocytic leukemia | Q40547433 | ||
| High dose cytosine arabinoside (HDARAC) in refractory acute leukemia | Q40866381 | ||
| Remission induction in acute nonlymphocytic leukemia: comparison of a seven-day and ten-day infusion of cytosine arabinoside in combination with adriamycin | Q43477883 | ||
| Recognition of drug resistance during remission induction therapy for acute non-lymphocytic leukemia: utility of day 6 bone marrow biopsy. | Q54505716 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | leukemia | Q29496 |
| P304 | page(s) | 19-32 | |
| P577 | publication date | 1984-09-01 | |
| P1433 | published in | British Journal of Haematology | Q4970200 |
| P1476 | title | Prediction of response of acute nonlymphocytic leukaemia to therapy with 'high dose' cytosine arabinoside. | |
| P478 | volume | 58 |
| Q37717088 | Cytosine arabinoside in the treatment of acute myeloid leukemia: the role and place of high-dose regimens |
| Q37732534 | Determinants of response and prediction of response to chemotherapy in acute myelogenous leukemia |
| Q54334708 | Flow cytometry DNA measurement for prediction of effect of therapy in acute leukemia. |
| Q42289001 | Fludarabine and arabinosylcytosine therapy of refractory and relapsed acute myelogenous leukemia |
| Q36065763 | Hematologic aspects of myeloablative therapy and bone marrow transplantation. |
| Q40711700 | Poor prognosis acute myelogenous leukemia |
| Q59315448 | Poor prognosis acute myelogenous leukemia: 1 – response to treatment with high dose cytarabine/mitoxantrone/ethyol @ (Amifostine) |
| Q68197644 | Predicting remission outcome in acute non-lymphocytic leukemia: General principles and their application to residual marrow leukemia |
| Q47639220 | Results of Therapy for Acute Myeloid Leukemia in First Relapse |
| Q35103330 | The treatment of acute myeloid leukemia in first relapse: a comprehensive review of the literature |
| Q69499477 | Treatment of relapsed and refractory acute leukaemia with high-dose cytosine arabinoside and etoposide |
| Q54157315 | Treatment of relapsed or refractory AML with intermediate-dose arabinosylcytosine (ara-C): confirmation of the importance of ara-C triphosphate formation in mediating response to ara-C. |
| Q37909059 | Treatment strategies in acute myeloid leukemia (AML). B. Second line treatment |
Search more.